Wijkstrom Joakim
SVP, Chief Marketing Officer
Wijkstrom Joakim has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 4, 2026.
On the most recent filing, Wijkstrom Joakim is listed as SVP, Chief Marketing Officer at Vanda Pharmaceuticals Inc. Inside the rolling window, Wijkstrom Joakim reported no open-market purchases and 1 open-market sale totaling $255K in VNDA.
Companies traded
Other insiders at VNDA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$255K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Wijkstrom Joakim made?
Wijkstrom Joakim has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Wijkstrom Joakim trade?
Wijkstrom Joakim has filed SEC Form 4 disclosures for 1 company, including VNDA.
When was Wijkstrom Joakim's most recent SEC Form 4 filing?
Wijkstrom Joakim's most recent SEC Form 4 filing on Tracefour is dated Mar 4, 2026.
What is Wijkstrom Joakim's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Wijkstrom Joakim is listed as SVP, Chief Marketing Officer.
What is Wijkstrom Joakim's total buy and sell value in the current window?
Inside the rolling retention window, Wijkstrom Joakim bought $0 and sold $255K based on SEC Form 4 filings.
What was Wijkstrom Joakim's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 30,800 VNDA shares on 2026-03-02, worth $255K, per SEC Form 4 filings.